Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer

Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer

In the field of drug repurposing, the use of statins for treating dyslipidemia is considered promising in ovarian cancer treatment based on epidemiological studies and basic research findings. Biomarkers should be established to identify patients who will respond to statin treatment to achieve clini...

Full description

Bibliographic Details
Main Authors: Yusuke Kobayashi, Takashi Takeda, Haruko Kunitomi, Fumiko Chiwaki, Masayuki Komatsu, Shimpei Nagai, Yuya Nogami, Kosuke Tsuji, Kenta Masuda, Hideaki Ogiwara, Hiroki Sasaki, Kouji Banno, Daisuke Aoki
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Pharmaceuticals
Subjects:
ovarian cancer
drug repurposing
statin
<i>VDAC1</i>
<i>LDLRAP1</i>
Online Access:https://www.mdpi.com/1424-8247/15/2/124

Internet

https://www.mdpi.com/1424-8247/15/2/124

Similar Items